Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Operating expenses:
Research and development	$ 20,311	$ 13,867	$ 54,735	$ 31,516
General and administrative	6,013	4,147	17,189	10,816
Depreciation and amortization	33	30	98	45
Total operating expenses	26,357	18,044	72,022	42,377
Loss from operations	(26,357)	(18,044)	(72,022)	(42,377)
Other income (expense)
Interest income	2,129	1,444	4,554	2,917
Foreign currency exchange gain (loss)	(20)	1	(166)	64
Tax credit income			797	797
Total other income, net	2,109	1,445	5,185	3,778
Net loss	$ (24,248)	$ (16,599)	$ (66,837)	$ (38,599)
Net loss per share:
Basic	$ (0.11)	$ (0.1)	$ (0.35)	$ (0.25)
Diluted	$ (0.11)	$ (0.1)	$ (0.35)	$ (0.25)
Weighted-average common shares outstanding:
Basic	211,847,651	174,696,191	192,398,514	152,778,072
Diluted	211,847,651	174,696,191	192,398,514	152,778,072
Other comprehensive income (loss):
Gain (loss) on foreign currency translation	$ 596	$ (318)	$ 263	$ (286)
Unrealized gain (loss) on short-term investments	583	(5)	307	(51)
Total comprehensive loss	$ (23,069)	$ (16,922)	$ (66,267)	$ (38,936)